(19)
(11) EP 2 863 983 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.05.2021 Bulletin 2021/20

(45) Mention of the grant of the patent:
07.04.2021 Bulletin 2021/14

(21) Application number: 13734525.2

(22) Date of filing: 17.06.2013
(51) International Patent Classification (IPC): 
A61N 1/04(2006.01)
 A61N 1/36(2006.01)
(86) International application number:
PCT/SE2013/050700
(87) International publication number:
WO 2014/003633 (03.01.2014 Gazette 2014/01)

(54)

MEDICAL THERAPY ARRANGEMENT

MEDIZINISCHE THERAPIEANORDNUNG

DISPOSITIF DE THÉRAPIE MÉDICALE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.06.2012 SE 1250685
26.06.2012 US 201261664282 P

(43) Date of publication of application:
29.04.2015 Bulletin 2015/18

(60) Divisional application:
21166903.1

(73) Proprietor: Exoneural Network AB
182 33 Danderyd (SE)

(72) Inventors:
  • WISTRAND, Jonas
    113 45 Stockholm (SE)
  • LUNDQVIST, Fredrik
    115 36 Stockholm (SE)
  • SJÖBERG, Emma
    127 41 Skärholmen (SE)
  • GAWELL, Johan
    113 28 Stockholm (SE)
  • HALLDÉN, Andreas
    116 20 Stockholm (SE)

(74) Representative: Burkard, Thierry 
40 rue de Stalingrad
68100 Mulhouse
68100 Mulhouse (FR)


(56) References cited: : 
WO-A1-2011/067327
US-A1- 2004 173 220
US-A1- 2011 288 604
 US-A- 5 018 521
US-A1- 2008 077 192
US-B1- 7 072 721
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).